YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study2

Inclusion Criteria: * 1 In line with the diagnostic criteria of Western medicine type 2 DKD ; * 2 18-80 years old, regardless of gender ; * 3 30ml / min / 1.73m2 ≤ eGFR \< 60ml / min / 1.73m2 ( eGFR was calculated according to CKD-EPI formula ) ; * 4 In line with the diagnostic criteria of qi deficiency and collateral stasis syndrome in traditional Chinese medicine ; * 5 hbA1c between 7-10 % ; * 6 uACR ≥ 300mg / g * 7 blood pressure ≤ 150 / 90mmHg ; * 8 signed the informed consent ; Exclusion Criteria: * 1 Patients who are currently receiving other traditional Chinese medicines and Chinese patent medicines with DKD therapeutic effects ; * 2 combined with other clear renal diseases, such as polycystic kidney disease, glomerulonephritis, renal tumors ; * 3 Patients with acute or chronic infection who needed treatment were judged by the researchers not suitable for inclusion in the study ; * 4 Patients who participated in any other research drug study and / or received or had received another research drug or intervention treatment ( within one month before signing the informed consent form ) ; * 5 patients who were allergic or contraindicated to the planned use of drugs ; * 6 There are serious acute or chronic diseases that the major researchers believe may pose an excessive risk to the subjects, including : patients with cardiovascular, cerebrovascular, lung, blood, digestive tract, liver, kidney, neuropsychiatric or infectious diseases ; * 7 Patients with a history of immu…